Sargramostim
Showing 26 - 50 of 536
Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)
Recruiting
- Metastatic Cancer
- Keytruda Injectable Product
- +4 more
-
Rochester, MichiganAscension Providence Rochester Hospital
Jun 15, 2022
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Falimarev
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 4, 2022
Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- Non-Small Cell Carcinoma of Lung, TNM Stage 4
- Granulocyte-Macrophage Colony-Stimulating Factor
- +4 more
-
Boston, MassachusettsTufts Medical Center
Oct 3, 2022
COVID-19 Trial in Belgium (Sargramostim, Control)
Completed
- COVID-19
- Sargramostim
- Control
-
Brugge, Belgium
- +3 more
Mar 1, 2021
Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)
Completed
- Head and Neck Cancer
- +3 more
- sargramostim
- oral salt and soda mouthwash
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 9, 2021
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Covid19, SARS-CoV Infection Trial in Argentina, United States (Sargramostim, Placebo)
Completed
- Covid19
- SARS-CoV Infection
- Sargramostim
- Placebo
-
Phoenix, Arizona
- +36 more
Feb 22, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Biliary Cancer Trial in San Francisco (Pembrolizumab, Sargramostim)
Completed
- Biliary Cancer
- Pembrolizumab
- Sargramostim
-
San Francisco, CaliforniaUniversity of California San Francisco
Jan 21, 2022
Prostate Cancer Trial in Madison (pTVG-HP, Nivolumab, GM-CSF)
Active, not recruiting
- Prostate Cancer
- pTVG-HP
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Feb 7, 2022
Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)
Active, not recruiting
- Mesothelioma
- +2 more
- Galinpepimut-S
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 23, 2022
Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +3 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Neuroblastoma (NB) Trial in New York (Irinotecan, temozolomide, Hu3F8)
Active, not recruiting
- Neuroblastoma (NB)
- Irinotecan
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 19, 2021
Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +8 more
-
Los Angeles, CaliforniaUSC CRS
Oct 26, 2021
Peripheral Artery Disease (PAD) Trial in Atlanta (GM-CSF, Placebo)
Recruiting
- Peripheral Artery Disease (PAD)
- GM-CSF
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Oct 8, 2021
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2b, Zidovudine, Sargramostim)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2b
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 26, 2021
HIV, Cytopenias Trial in Buffalo (Zidovudine, Sargramostim)
Completed
- HIV Infections
- Cytopenias
- Zidovudine
- Sargramostim
-
Buffalo, New YorkSUNY / Erie County Med Ctr at Buffalo
Oct 27, 2021
Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Lung Non-Squamous Non-Small Cell Carcinoma
- +3 more
- CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- Sargramostim
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 11, 2022
Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)
Withdrawn
- Lymphoma
- rituximab
- +7 more
-
Washington, District of Columbia
- +1 more
Oct 19, 2021
Advanced Adenocarcinoma, Advanced Malignant Solid Tumor, Metastatic Adenocarcinoma Trial in Sacramento (Antineoplastic Vaccine,
Recruiting
- Advanced Adenocarcinoma
- +5 more
- Antineoplastic Vaccine
- Sargramostim
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 29, 2021
Solid Tumor Trial in New Haven (sargramostim, topotecan HCl)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- sargramostim
- topotecan hydrochloride
-
New Haven, ConnecticutYale Comprehensive Cancer Center
Aug 13, 2020
Sarcoma, Kaposi, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Bleomycin sulfate
- +4 more
-
Los Angeles, California
- +4 more
Oct 26, 2021
Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)
Recruiting
- Neuroblastoma
- 131I-MIBG
- +4 more
-
Los Angeles, California
- +11 more
Jan 30, 2023